Ganzhou Hemay Pharmaceutical Co., Ltd

This completed Phase 1 study tested how the psoriasis drug Hemay005 is processed in people with mild to moderate kidney impairment compared to those with normal kidneys. 26 adults took a single dose, and researchers measured drug levels in the blood to guide future dosing for pat…

This study tested how Hemay005 tablets affect the breakdown of another drug (midazolam) and whether they change heart rhythm or inflammation levels. It involved 20 healthy adults with psoriasis. The goal was to gather safety and interaction information, not to treat the disease.